0001437749-26-004524
SEC filingHuntsman Corporation reported a net loss of $284 million attributable to the parent for fiscal year 2024, driven by an operating loss of $131 million despite generating $5.68 billion in revenue. The company's gross profit was $751 million, but this was offset by significant operating expenses totaling $882 million, which included $148 million in restructuring, settlement, and impairment provisions. Cash flow from operations was positive at $289 million, supporting capital expenditures of $173 million and dividend payments of $146 million to common stockholders. The balance sheet shows total assets of $7.01 billion, with total liabilities of $4.06 billion and total equity of $2.96 billion, indicating a leveraged financial position. The company's performance reflects challenges in profitability amid ongoing restructuring efforts.
Huntsman Corporation reported challenging financial results for fiscal year 2024, ending December 31, 2025. The company generated $5.68 billion in revenue but recorded a net loss attributable to the parent of $284 million. This loss was primarily driven by an operating loss of $131 million, as total operating expenses of $882 million exceeded gross profit of $751 million. Key expense items included $148 million in restructuring, settlement and impairment provisions, $670 million in selling, general and administrative expenses, and $120 million in research and development. The loss from continuing operations before taxes was $192 million, with income tax expense of $26 million resulting in a loss from continuing operations of $218 million. Discontinued operations contributed an additional $9 million loss.
The filing provides consolidated revenue of $5.68 billion but does not disclose segment-level revenue breakdowns, geographic mix, or specific growth drivers. The XBRL data and document content present only consolidated financial statements without dimensional segment data. Cost of goods sold was $4.93 billion, resulting in gross profit of $751 million. No comparative prior period revenue figures are provided in the current filing, preventing year-over-year growth analysis.
The company's gross margin was 13.2% ($751M/$5.68B), reflecting the relationship between revenue and cost of goods sold. Operating margin was negative 2.3% (-$131M/$5.68B), indicating profitability challenges at the operating level. The cost structure shows significant operating expenses, with selling, general and administrative expenses representing 11.8% of revenue and research and development at 2.1% of revenue. Restructuring, settlement and impairment provisions accounted for 2.6% of revenue, contributing to the operating loss position.
Operating activities generated $289 million in cash flow, with $298 million from continuing operations offset by $9 million used in discontinued operations. Free cash flow (operating cash flow minus capital expenditures) was $116 million ($289M - $173M). The balance sheet shows total assets of $7.01 billion, including $2.06 billion in current assets with $429 million in cash and cash equivalents. Total liabilities were $4.06 billion, including $2.01 billion in total debt ($353M current portion + $1.66B long-term). Total equity was $2.96 billion, resulting in a debt-to-equity ratio of 0.68. The company maintained liquidity with a current ratio of 1.30 ($2.06B/$1.59B).
The filing does not contain management guidance, strategic priorities, or specific risk factor discussions in the provided content. The XBRL data and document text focus exclusively on historical financial statements without forward-looking statements or outlook commentary. Investors should refer to the complete 10-K filing for management discussion and analysis, risk factors, and future outlook sections that may provide additional context beyond the financial statement data presented here.